Personal Satisfaction: Clinical Trials

48 trials for Personal Satisfaction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 completed, 7 unknown, 6 recruiting, 2 active not recruiting. 48 Phase 2, 6 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 248Completed 30, Unknown 7, Recruiting 6, Active not recruiting 2, Enrolling by invitation 1, Not yet recruiting 1, Withdrawn 1
Phase 16Completed 4, Unknown 1, Withdrawn 1
Phase 34Completed 3, Unknown 1

Follow Personal Satisfaction: new trials by email Literature Review of Personal Satisfaction trials Research Report on Personal Satisfaction

Trials (filtered) newest first · largest first

All 48 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Psilocybin for Depression in Veterans
Psilocybin, modafinil, zolpidem - Major Depression
Phase 2Not yet recruitingVA Office of Research and Development1502027-01-012026-10-26
Long-Term Outcomes Following HBOT
Hyperbaric Oxygen Therapy (HBOT) - Traumatic Brain Injury, Post-Concussive Symptoms
Phase 2RecruitingSummit Hyperbarics and Wellness352026-06-182026-07-28
Impact of Smell Testing on Health Outcomes
Patient-centered information and education - Olfactory Dysfunction, Wellbeing
Phase 2RecruitingMonell Chemical Senses Center10002026-05-292026-10-06
Evaluating the Effectiveness of the Common Elements Treatment Approach (CETA) in Peru: Mechanisms of Individual and Intergenerational Change
Common Elements Treatment Approach, Enhanced Case Managment - Violence, Parenting
Phase 2RecruitingUniversity of Notre Dame6002026-05-182026-06-25
Sleep Health in U.S. Marines
Sleep Leadership, Circadian, Light, and Sleep Skills in Shipboard Military (CLASS-MC) Personnel Program, Insomnia Coach - Depression, Suicidality
Phase 2RecruitingSan Diego State University8602026-03-312026-04-16
Mindfulness-Assisted Psychedelic Therapy
Psilocybin plus mindfulness training, Psilocybin - Mental Health
Phase 2RecruitingUniversity of Southern California402025-07-302026-08-06
Impact of a Medical-Financial Partnership Intervention on Parent Mental Health, Perinatal Outcomes, and Child Developmental Risk
Medical-Financial Partnership Support - Child Development, Mental Health
Phase 2Enrolling by invitationUniversity of California, Los Angeles12002025-07-072026-07-22
Novel and Conventional Interventions for Cognitive and Emotional Flexibility in Patient Trauma
D-Cycloserine (DCS), Transcranial Magnetic Stimulation, Unified Protocol - Depression, Anxiety
Phase 2Active not recruitingMclean Hospital752025-06-012026-10-09
Promoting Active Therapy: Path to Wellness
Walk-and-talk therapy - Depression, Anxiety, Physical Activity
Phase 2RecruitingKansas State University602025-02-282025-03-05
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
Fasedienol Nasal Spray - Placebo Nasal Spray, Fasedienol Nasal Spray - Fasedienol Nasal Spray, Placebo Nasal Spray - Placebo Nasal Spray - Social Anxiety Disorder
Phase 2CompletedVistaGen Therapeutics, Inc.612025-01-092026-11-04
Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs
Collaborative drug therapy management model, Cabotegravir/Rilpivirine - Hiv
Phase 2Active not recruitingYale University502024-08-012026-10-13
Self-Management Program for AIS D SCI
SCI Self-Management for AIS D - Psychological Well-Being, Spinal Cord Injuries
Phase 1 / Phase 2WithdrawnVA Office of Research and Development2024-05-012026-03-13
Cannabinoids as a Treatment for Insomnia in Major Depression
25:1 CBD/THC, 5:1 CBD/THC, Placebo - Insomnia, Depressive Disorder, Major
Phase 2CompletedSt. Joseph's Healthcare Hamilton142023-08-282026-01-22
Satisfaction With FreeStyle Libre 2 Monitoring Versus Capillary Blood Glucose Monitoring in People With DM2
FreeStyle Libre 2, flash glucose monitoring - Diabetes Mellitus, Type 2
Phase 2CompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau502022-11-282024-10-03
The CANabidiol Use for RElief of Short Term Insomnia
50 mg Cannabidiol (CBD), Placebo, 100 mg Cannabidiol (CBD) - Sleep Disturbance, Insomnia
Phase 2CompletedBod Australia2082022-05-012023-08-16
Antibiotic Loaded Bone Cement in Prevention of Periprosthetic Joint Infections in Primary Total Knee Arthroplasty
ALBC vs plain bone cement - Osteoarthritis, Knee
Phase 2UnknownThe Norwegian Arthroplasty Register91722021-01-142021-01-19
Oxytocin to Treat PTSD
Oxytocin, Placebo - PTSD
Phase 2CompletedVA Office of Research and Development1802021-01-012026-03-11
Peer Support Intervention to Mitigate Social Isolation and Stigma of Adolescent Motherhood in Zimbabwe
Young Women of Today - Mental Health Disorder, Social Isolation
Phase 2CompletedWest Chester University of Pennsylvania1832018-10-012022-02-15
Effect of Different Types of Crowns on Patient Satisfaction and Clinical Assesment
Allceram, hybrid crown - Personal Satisfaction
Phase 2UnknownCairo University242017-01-012016-10-11
Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload
Deferasirox granule formulation, Deferasirox DT formulation - Transfusion-dependent Anemia
Phase 2CompletedNovartis Pharmaceuticals2242015-10-212024-09-19

Showing 20 of 48. Sign in to see all of them.

Narrower conditions

Psychological Well-Being (40)  ·  Depression (12)  ·  Anxiety Disorders (9)  ·  Stress Disorders, Post-Traumatic (6)  ·  Mental Disorders (5)  ·  Depressive Disorder, Major (3)  ·  Motor Activity (3)  ·  Phobia, Social (3)  ·  Sleep Initiation and Maintenance Disorders (3)  ·  Pain (2)  ·  Patient Compliance (2)  ·  Phobic Disorders (2)  ·  Sleep Wake Disorders (2)  ·  Substance-Related Disorders (2)

Broader conditions

Behavior (48)  ·  Mental Disorders (21)  ·  Behavioral Symptoms (14)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Signs and Symptoms (7)  ·  Nervous System Diseases (6)  ·  Neurologic Manifestations (6)  ·  Stress Disorders, Traumatic (6)  ·  Trauma and Stressor Related Disorders (6)  ·  Social Behavior (4)  ·  Chemically-Induced Disorders (3)  ·  Depressive Disorder (3)  ·  Dyssomnias (3)  ·  Mood Disorders (3)

Interventions

Cognitive Behavioral Therapy (4)  ·  Hypericum extract LI 160 (3)  ·  Psilocybin (2)  ·  Sodium Chloride (2)  ·  (tris(diphenylphosphinomethyl)phenylborate)(p-tolylnitrido)iron(I) (1)  ·  AllCeram (1)  ·  Alprazolam (1)  ·  Cannabidiol (1)  ·  Capsules (1)  ·  Cycloserine (1)  ·  Deferasirox (1)  ·  Dexmedetomidine (1)  ·  Educational Status (1)  ·  Employment, Supported (1)  ·  Escitalopram (1)

Sponsors

VA Office of Research and Development (5)  ·  National Center for Complementary and Integrative Health (NCCIH) (4)  ·  Arizona State University (1)  ·  Bod Australia (1)  ·  Cairo University (1)  ·  Central Union for the Welfare of the Aged (1)  ·  Charite University, Berlin, Germany (1)  ·  Collinge and Associates, Inc. (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Heidelberg University (1)  ·  Isfahan University of Medical Sciences (1)  ·  Kansas State University (1)  ·  Kaohsiung Medical University Chung-Ho Memorial Hospital (1)  ·  Kent State University (1)  ·  Massachusetts General Hospital (1)

Countries

United States (30)  ·  Egypt (2)  ·  France (2)  ·  Germany (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Finland (1)  ·  Hungary (1)  ·  India (1)  ·  Iran (1)  ·  Italy (1)  ·  Lebanon (1)

Top investigators

Kenneth Kobak, PhD (2)  ·  Adam Schickedanz, MD PhD (1)  ·  Ahmad Shavakhi, M.D. (1)  ·  Amy Birney, MPH, MCHES (1)  ·  Anne Klibanski, MD (1)  ·  Baruch R Cahn, MD, PhD (1)  ·  Benicio N Frey, MD, MSc, PhD (1)  ·  Bert Hayslip, Ph.D. (1)  ·  Chiwoneso Tinago, PhD (1)  ·  Cynthia Price, PhD (1)  ·  Danielle Reed (1)  ·  Elizabeth B Khalil, BSc MSc PhD (Cant.) (1)  ·  Emily Schmied, PhD (1)  ·  Erinne Meenaghan, NP (1)

Results publications

PMID 18457236, PMID 20815872, PMID 21663696, PMID 23924065, PMID 24251855, PMID 24977401, PMID 24983382, PMID 27678169, PMID 28934782, PMID 30188171, PMID 31219558, PMID 32561468, PMID 33393377, PMID 33509845, PMID 33884617, PMID 36798485, PMID 37957412

NIH funding

I21RX004417 (1), K08MH001662 (1), R01HD115000 (1), R01HD116815 (1), R01MH077596 (1), R01MH083657 (1), R01NR012256 (1), R21MH066131 (1), R21NR011149 (1), R42MH087322 (1), R44DC022498 (1)